Midluteal matrix metalloproteinase and tissue-inhibiting metalloproteinase plasma levels after embryo transfer.
This study demonstrates significant differences in the midluteal concentrations of active matrix metalloproteinase (MMP)-1, MMP-2, and total MMP-3 between patients who conceived and those who did not after day 3 ET.
Department of Obstetrics, Gynecology, and Women's Health, University of Louisville, Louisville, Kentucky 40292, USA. maherabdallah@aol.com
Maher A
MA
Abdallah
Steven T
ST
Nakajima
Abby C
AC
Eblen
Alberto
A
Carrillo
Cicek
C
Gercel-Taylor
D010064:Embryo Implantation / Q000502:physiology*; D004624:Embryo Transfer; D004967:Estrogens / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D008183:Luteal Phase / Q000502:physiology; D008297:Male; D020782:Matrix Metalloproteinases / Q000097:blood*; D010865:Pilot Projects; D011247:Pregnancy; D011374:Progesterone / Q000097:blood; D011446:Prospective Studies; D019714:Tissue Inhibitor of Metalloproteinases / Q000097:blood*
D004967:Estrogens; D019714:Tissue Inhibitor of Metalloproteinases; D011374:Progesterone; D020782:Matrix Metalloproteinases